Charge-to-digital converter for time domain dual life reference

By employing a charge-to-digital converter architecture for miniaturized wireless devices and dual lifetime reference calculations in the time domain, the problems of large size and high power consumption in blood gas measurement devices have been solved, enabling accurate measurement of carbon dioxide and portable use, suitable for remote monitoring of patients' respiratory status.

CN122458910APending Publication Date: 2026-07-24WORCESTER POLYTECHNIC INSTITUTE
5 Cites 0 Cited by

Patent Information

Application Number
CN202480081906.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-10-23
Filing Date
2024-10-23
Publication Date
2026-07-24

AI Technical Summary

Technical Problem

In the existing technology, blood gas measurement devices are usually large in size and have high power requirements, making them unportable. Furthermore, conventional methods require connection to auxiliary computing devices, which limits their application outside of clinical settings.

Method used

By employing miniaturized wireless devices and utilizing a charge-to-digital converter (CDC) architecture, and through time-domain dual lifetime reference calculations, the luminescence response of a carbon dioxide-sensitive membrane is used to achieve accurate measurement of transdermal carbon dioxide, reducing interference from confounding factors.

Benefits of technology

It achieves high-precision measurement of carbon dioxide on the skin surface, reduces the size and power requirements of the device, makes the device portable and suitable for remote monitoring of patients' respiratory status, and increases the likelihood of patients being discharged early.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

A wearable, miniaturized wireless device detects the luminescent response of a carbon dioxide sensitive film to provide an accurate measurement of transdermal carbon dioxide that diffuses across the skin, thereby providing an accurate reflection of a human's blood carbon dioxide level. The device employs a charge-to-digital converter (CDC) architecture operable to implement time domain dual life reference calculations to measure transcutaneous carbon dioxide. This potential product enables a highly accurate and precise measurement of percutaneous carbon dioxide while minimizing the interference of confounding factors.
Need to check novelty before this filing date? Find Prior Art